Drugs

Acknowledgement to Referees

Lamivudine/Tenofovir Disoproxil Fumarate is an Appropriate PrEP Regimen

Andrew Mujugira, Jared M. Baeten, Ioannis Hodges-Mameletzis, Jessica E. Haberer

A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery

Nameer van Oosterom, Michael Barras, Robert Bird, Iulian Nusem, Neil Cottrell

The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review

Kottil Rammohan, Patricia K. Coyle, Elke Sylvester, Andrew Galazka, Fernando Dangond, Megan Grosso, Thomas P. Leist

Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review

Fabrizio Cantini, Delia Goletti, Linda Petrone, Saied Najafi Fard, Laura Niccoli, Rosario Foti

Symptomatic Efficacy of Pharmacological Treatments for Knee Osteoarthritis: A Systematic Review and a Network Meta-Analysis with a 6-Month Time Horizon

C. Beaudart, L. Lengelé, V. Leclercq, A. Geerinck, D. Sanchez-Rodriguez, O. Bruyère, J. Y. Reginster

Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity

Kueiyu Joshua Lin, Sebastian Schneeweiss, Helen Tesfaye, Elvira D’Andrea, Jun Liu, Joyce Lii, Shawn N. Murphy, Joshua J. Gagne

Venetoclax: A Review in Previously Untreated Chronic Lymphocytic Leukaemia

Hannah A. Blair

Sofpironium Bromide: First Approval

Julia Paik

Filgotinib: First Approval

Sohita Dhillon, Susan J. Keam

Correction to: Ripretinib: First Approval

Sohita Dhillon

Correction to: Trastuzumab Emtansine: A Review of Its Adjuvant Use in Residual Invasive HER2-Positive Early Breast Cancer

Katherine A. Lyseng-Williamson